2017 Edition Global Breast Cancer Industry Analysis

1
Global Breast Cancer Market Industry Analysis
Outlook (2017-2021)
Published February 2017 Pages 70 Price US 800
(Single User License)

• E-mail sales_at_marketreportsonline.com
• Tel [phone]

2
Global Breast Cancer Market Industry Analysis
Outlook (2017-2021)
Breast cancer defines a malignant tumor that
has developed from cells in the breast. Some
breast cancers are called in situ as they are
confined within the ducts (ductal carcinoma in
situ or DCIS) or lobules (lobular carcinoma in
situ or LCIS) where they originated. Although,
less commonly, breast cancer can also instigate
in the stromal tissues, which include the fatty
and fibrous connective tissues of the breast. In
the early stages, breast cancer may not cause any
symptoms. A lump may be too small to feel or to
cause any unusual changes that could be noticed
on own. Typically, an abnormal area shows up on a
screening mammogram which leads to further
testing. Several risk factors including smoking
and alcohol consumption, exposure to estrogen,
gender, age, radiation therapy, family history
and personal history are linked to the growth of
breast cancer. The global market for breast
cancer has grown swiftly over the past few years
driven by introduction of several new drugs and
biosimilars. The overall breast cancer market
remained mainly dominated by the generic drugs.
The future market for breast cancer will grow in
the coming years as there exist unmet need for
new drugs that would overcome resistance and
prevent recurrence of the disease. The global
breast cancer market is likely to grow strongly
in the coming years driven by rising healthcare
expenditure, rising diabetic and obese
population, increased spending on medicines,
increasing consumption of alcohol and tobacco and
rising female population above 65 years of age.
Key trends of the market includes rising
development of PARP inhibitors, clinical trials
of CDK4/6 inhibitors and introduction of new
imaging tests. However, growth of the market can
be hindered by several factors including drug
development challenges in developing countries,
long term side effects of drugs and heavy costs
associated with drug development.
3
Global Breast Cancer Market Industry Analysis
Outlook (2017-2021)
The report Global Breast Cancer Market Industry
Analysis Outlook (2017-2021) provides an
extensive research and detailed analysis of the
present market along with future outlook. The
report discusses the major growth drivers and
challenges of the market, covering the U.S.,
Europe and APAC regions along with the global
market. The report profiles the key players of
the market including Johnson Johnson, AbbVie,
AstraZeneca and Roche. Key Topics Covered in
Global Breast Cancer Industry Report 1.
Introduction 2. Global Breast Cancer Market 3.
Regional Breast Cancer Market 4. Market
Dynamics 5. Competition 6. Company
Profiles Other Related Reports on Breast Cancer
Market   Breast Cancer Treatment Drug Industry
Forecasts - China Focus This study focuses on
China's Breast Cancer Treatment Drug industry
forecasts. In the two past decades, the industry
has been growing at a fast pace. The dramatic
expansions of the manufacturing capabilities and
rising consumer consumptions in China have
transformed China's society and economy. China is
one of the world's major producers for industrial
and consumer products. Far outpacing other
economies in the world, China is the world's
fastest growing market for the consumptions of
goods and services. Complete report available
with Table of Contents at http//www.marketreports
online.com/426033.html.
4
Global Breast Cancer Market Industry Analysis
Outlook (2017-2021)
Global Cancer Diagnostic Market with Focus on
Lung and Breast Cancer (2016-2020) The report
entitled Global Cancer Diagnostic Market with
Focus on Lung and Breast, provides analysis of
the global cancer diagnostics market and the US
cancer diagnostics market, with detailed analysis
of market size and growth, penetration and market
share. The report also provides the analysis of
the global and the US cancer market, by
prevalence, new cases, deaths, type of cancers,
etc. The report provides the market sizing of the
global lung and breast cancer diagnostic market
by value and by segments. Complete report
available with Table of Contents at
http//www.marketreportsonline.com/505561.html. H
ormone Refractory Breast Cancer-Pipeline
Insights, 2017 This report provides in depth
insights on the pipeline drugs and their
development activities around the Hormone
Refractory Breast Cancer. The DelveInsight'sReport
covers the product profiles in various stages of
development including Discovery, Pre-clinical,
IND, Phase I, Phase II, Phase III and
Preregistration. Report covers the product
clinical trials information and other development
activities including technology, licensing,
collaborations, acquisitions, fundings, patent
and USFDA EMA designations details.
DelveInsight's Report also provides detailed
information on the discontinued and dormant drugs
that have gone inactive over the years for
Hormone Refractory Breast Cancer. Complete report
available with Table of Contents at
http//www.marketreportsonline.com/565269.html.
Explore more healthcare market research as
well as other newly published reports by Koncept
Analytics at http//www.marketreportsonline.com/pu
blisher/koncept-analytics-market-research.html.
5
Global Breast Cancer Market Industry Analysis
Outlook (2017-2021)
About Us MarketReportsOnline comprises of an
online library of 2,50,000 reports and in-depth
market research studies of over 5000 micro
markets. We provide 24/7 online and offline
support to our customers. Get in touch with us
for your needs of market research
reports. Contact Us Ritesh Tiwari 2nd Floor,
Metropole, Next to Inox Theatre, Bund Garden
Road, Pune, Maharashtra, India Tel [phone]
5441 E-mail sales_at_marketreportsonline.com
http//www.marketreportsonline.com/